The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.

Weiner, G J

Weiner, G J.

Affiliation

Weiner GJ; University of Iowa Cancer Center and Department of Internal Medicine, University of Iowa, Iowa City 52242, USA. george-weiner@uiowa.edu

J Leukoc Biol ; 68(4): 455-63, 2000 Oct.

Article in En | MEDLINE | ID: mdl-11037965

Subject(s)

Adjuvants, Immunologic/pharmacology; Oligodeoxyribonucleotides/pharmacology; Adjuvants, Immunologic/chemistry; Adjuvants, Immunologic/therapeutic use; Adjuvants, Immunologic/toxicity; Animals; Anti-Asthmatic Agents/therapeutic use; Asthma/drug therapy; Clinical Trials as Topic; CpG Islands; DNA, Bacterial/genetics; Drug Evaluation, Preclinical; Humans; Hypersensitivity/drug therapy; Immunization; Lymphocyte Activation/drug effects; Lymphokines/metabolism; Macrophage Activation/drug effects; Mice; Models, Animal; Neoplasms/drug therapy; Oligodeoxyribonucleotides/chemistry; Oligodeoxyribonucleotides/therapeutic use; Oligodeoxyribonucleotides/toxicity; Reactive Oxygen Species; Species Specificity; T-Lymphocyte Subsets/drug effects; T-Lymphocyte Subsets/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oligodeoxyribonucleotides / Adjuvants, Immunologic Limits: Animals / Humans Language: En Journal: J Leukoc Biol Year: 2000 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links